Trial · NCT00876993
Results by group85
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 85
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Measurement of Number of Adverse Events | Cohort 1 - Dose Level 1 | Grade 1 adverse events | 4 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 2 - Dose Level 0 | Grade 1 adverse events | 6 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 3 - Dose Level 1 | Grade 1 adverse events | 3 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 4 - Dose Level 2 | Grade 1 adverse events | 5 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 5 - Dose Level 1 | Grade 1 adverse events | 3 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 1 - Dose Level 1 | Grade 2 adverse events | 4 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 2 - Dose Level 0 | Grade 2 adverse events | 3 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 3 - Dose Level 1 | Grade 2 adverse events | 3 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 4 - Dose Level 2 | Grade 2 adverse events | 5 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 5 - Dose Level 1 | Grade 2 adverse events | 2 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 1 - Dose Level 1 | Grade 3 adverse events | 3 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 2 - Dose Level 0 | Grade 3 adverse events | 1 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 3 - Dose Level 1 | Grade 3 adverse events | 1 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 4 - Dose Level 2 | Grade 3 adverse events | 4 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 5 - Dose Level 1 | Grade 3 adverse events | 1 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 1 - Dose Level 1 | Grade 4 adverse events | 1 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 2 - Dose Level 0 | Grade 4 adverse events | 0 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 3 - Dose Level 1 | Grade 4 adverse events | 0 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 4 - Dose Level 2 | Grade 4 adverse events | 0 | Adverse events | |
| Measurement of Number of Adverse Events | Cohort 5 - Dose Level 1 | Grade 4 adverse events | 0 | Adverse events |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00876993/results